Cancer Cell - Fasting as a treatment for cancer, Market Size Is Anticipated To Reach US$ 14,803.5 Million at a CAGR of 8.20% by 2027
Global Cancer Cell Market
Cancer cells are cells that divide relentlessly, forming solid tumors or flooding the blood with abnormal cells. Cancer cells have the ability to travel to or invade nearby tissues and thus spread to different areas of the body. In the human body, cancer cells are generated through genetic and epigenetic changes that may be either inherited or more often, caused by carcinogens such as tobacco and others. Many therapies are available for the treatment of cancer such as targeted drug therapy, hormone therapy, immunotherapy, radiation therapy, chemotherapy, and others.
The global cancer cell market is estimated to be valued at US$ 8,525.5 million in 2020 and is expected to exhibit a CAGR of 8.20 % during the forecast period (2020-2027).
Get Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/4338
The COVID-19 pandemic worldwide has impacted the financial status of the major companies in the cancer cell market. The pandemic has adversely impacted the healthcare sector in several ways such as production, research and development, and supply of drugs, as well as the growth of the pharmaceutical businesses due to lockdown imposed by governments of several countries across the globe. The nationwide lockdown has led to the shutdown of industrial establishments, barring disruption of the supply chain of raw materials and medicines for the manufacture and therapeutic use of essential commodities.
Rising incidence of cancer, such as breast cancer, lung cancer, and others, worldwide is expected to drive the global cancer cell market growth over the forecasted period. According to the World Health Organization (WHO), cancer is the second leading cause of death worldwide, accounting for around 9.6 million deaths in 2018.
Moreover, market players are adopting various strategies, such as partnership and collaboration, to strengthen their market position, which, in turn, is expected to propel the global cancer cell market growth. For instance, in 2018, Pfizer and Allogene partnered to develop an investigational CAR-T cell therapy for the cancer treatment.
Tailored Information as per niche requirement:
LIMITED TIME OFFER - Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/4338
Stringent regulations for approval of cancer cell therapies are expected to hamper growth of the global cancer cell market.
By Cancer Cell Type:
- Radiation Therapy
- Targeted Drug Therapy
- Hormone Therapy
By End User:
- Diagnostic Laboratories
- Specialty Clinics
- Hospital & Clinics
- North America
- Latin America
- Asia Pacific
- Middle East and Africa
North America is expected to witness significant growth in the global cancer cell market due to the presence of major players in the region. Market players are adopting various strategies such as partnership and collaboration to develop safe and effective treatments for various types of cancer. For instance, in August 2020, Siemens Healthineers teamed up with Varian Medical Systems to build out its cancer care offerings and provide a platform spanning screening and diagnosis to treatment delivery and recovery.
Read Press Release: https://www.coherentmarketinsights.com/press-release/cancer-cell-market-3598
Major players operating in the global cancer cell market are GE Healthcare Novartis International AG, Abbott Laboratories, Arcellx, Kite Pharma, Cellectis, Autolus Therapeutics, Celyad Oncology, GammaDelta Therapeutics Ltd., Crescendo Biologics Limited, Bio-Rad Laboratories Inc, QIAGEN Inc, Merck Millipore, Thermo Fisher Scientific, and Siemens Healthineers AG.
Other Related News:
Lung Cancer Diagnostic And Screening Market To Surpass US$ 3,515.9 Million By 2028
Cancer Supportive Care Products Market To Reach US$ 40,884.0 Million By 2027
Cancer Diagnostics Market To Reach US$ 83,641.9 Million By 2027
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- Coherent Market Insights
- Nirav Gokani
- Website: Cancer Cell Market